Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

Maropitant Citrate Tablet Manufacturer

Open
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This subcontract involves the manufacture of FDA-regulated Maropitant Citrate 160mg tablets for prime contractors supporting the Department of Defense Medical Supply Chain Pharm FSA. The scope of work encompasses the full production cycle, including the chemical synthesis of the active pharmaceutical ingredient, formulation, tablet compression, and primary packaging into blister packs of four tablets per perforated sheet. To ensure quality and regulatory compliance, the manufacturer must utilize pharmaceutical-grade tablet presses and operate within cGMP-compliant facilities. The final deliverable consists of four packages of tablets that adhere to all medical specifications and maintain a minimum shelf-life of 36 months. This project falls under NAICS code 325412 and is performed at an APO location. Interested parties should note the response deadline of November 12, 2026.

General Info

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

APO, AE, 09227-0000, USA

Set-Aside

NONE

Documents

This scope was carved out of SPE2DP-27-T-0251.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

MAROPITANT CITRATE

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
ContactsNo contacts available
OfficeN/A
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Manufactures FDA-regulated Maropitant Citrate 160mg tablets for prime contractors on DLA Medical Supply Chain Pharm FSA projects. Performs chemical synthesis of API, formulation, compression of tablets, and primary packaging into blister packs of 4 tablets per perforated sheet. Requires pharmaceutical-grade tablet presses and cGMP-compliant facilities. Delivers 4 packages of tablets meeting all medical specifications and a 36-month shelf-life.

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
DIBBS
HYDROGEN PEROXIDE TOPI
Solicitation # SPE2DP-27-T-0247
Solicitation SPE2DP-27-T-0247 is a request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of one bottle of Hydrogen Peroxide Topical Solution, USP. The required item is a 3% stabilized topical solution for external use, provided in a 473 milliliter bottle. The delivery is required within 20 days after receipt of the order, with the place of performance and delivery located in Eastover, South Carolina. Inspection and acceptance will occur at the destination in accordance with FAR 52.246-2. The product is regulated by the FDA and classified as a hazardous material, requiring a current Material Safety Data Sheet to be provided to the DLA electronic mailbox and included with each shipment. Packaging must comply with MIL-STD-2073-1E, Special Packaging Instructions MPPWN00001, and Medical Marking Standard No. 1. For shipments via military aircraft, compliance with DLAI 4145.3 is mandatory. Additionally, the contractor must provide a signed certification on DD Form 250 confirming that the package configuration meets 49 CFR and ICAO or IMDG requirements. Administrative requirements include the use of the Wide Area WorkFlow system for electronic invoicing and receiving reports. The contract incorporates several federal regulations, including the Buy American and Balance of Payments Program (DFARS 252.225-7001), safeguarding of covered defense information (DFARS 252.204-7012), and prohibitions on certain telecommunications equipment (DFARS 252.204-7018). Offerors must also validate their representations and certifications within the System for Award Management.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 6 days
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS